The Unmasking of Haemagglutinin in Extracts of
Vaccinia-infected Calf Tissue (Accepted 25 November 1968) Certain normal fowl cells are agglutinated by extracts of chick choriaUantois (CAM) infected with vaccinia virus (Nagler, 1942; Dekking & van Dillen, 1968) . The haemagglutinating activity (HA) of the extracts is inhibited by rabbit anti-vaccinia serum (AVS) but not by preimmunization serum (NRS). Vaccinia HA is not essential to virus production: it is a particle separate from the virus (Burnet & Stone, 1946) ; and some strains of vaccinia neither produce HA nor elicit antibody to HA in rabbits (Cassel, I957; Cassel & Fater, 1958) . It has been reported also that HA production is host dependent; some vaccinia virus strains produce HA in rabbit dermis and CAM but not in calf dermis (Stone & Burnet, I946) .
Opportunity arose to examine calf dermis infected with the EVANS strain of vaccinia. Calf dermal pulp was collected 5 days after scarification. It was extracted three times successively with phosphate buffer, pH 7"4, I = o'o5. Extractions were made at 4 ° and were completed within 16 hr of collection of the pulp. Most of the virus was removed from the pooled extracts by centrifugation at 6ooog for 3o min.
Portions of 'virus-free' extract were subjected to ultrasonic treatment for different times using an MSE-Mullard ultrasonic disintegrator (approximately 17"5 kcyc., small probe, output 50 w). Treated extracts were tested immediately for HA. Tests were made in 1% NRS by the method of Chu (I948) using a '2 +' agglutination as end point. All tests included controls to show that any HA demonstrated was inhibited by AVS (Table I) .
Untreated extracts contained no HA. Virus-specific HA was found in treated extracts to a maximum titre of 1/16. The activity declined on storage at 4 ° and disappeared by 72 hr. Activity was partially restored by further ultrasonic treatment. Additional experiments showed that the HA demonstrable in infected calf dermis agglutinated fowl cells only from those birds which were positive for HA present in CAM infected with EVANS or other strains of vaccinia virus. It was concluded that virus-specific HA was produced in vaccinia-infected calf dermis but that the activity was normally masked.
Further experiments were done to elucidate the masking of HA. Vaccinia HA was prepared from CAM infected with the EVANS strain of virus. Portions of the preparation were incubated for 30 min. at 37 ° with equal volumes of various calf materials (Table 2) .
Vaccinia HA was stable under the condition of incubation and was not inhibited by calf serum taken before vaccination. Inhibition was demonstrated, however, with extracts of vaccinia-infected calf dermis. When particulate matter including masked HA was removed from these extracts by centrifugation at IOO,OOOg for 3 hr the supernatant fluid was still inhibitory. This supernatant fluid was fractionated on DEAESephadex and one fraction alone (eluted with o-I4M-NaC1 in phosphate buffer, pH 7"4, I = 0.02) inhibited HA. For these last experiments tissue extracts were Short communications dialysed against distilled water until free from salt, dried from the frozen state and reconstituted in o'9 % saline. Concentrations given in Table 2 are those of undiffusible materials in o'9 % saline.
These experiments suggest that an inhibitor of vaccinia HA is present in vacciniainfected calf dermis. Results with DEAE-Sephadex suggest that it is a single protein, but it is not known whether the substance is of host or virus origin. The inhibitor can be separated from HA in infected calf extracts by ultrasonic treatment, thus allowing HA to be demonstrated. However, recombination of HA and inhibitor occurs readily even at 4 ° . Virus-free extract IO mg./ml. I6 4 (3) after ioo,ooog for 3 hr at < 4 1o mg./ml. 5 o'14 M-NaC1 fraction from DEAE-16 Sephadex of (4) at 2 mg./ml.
Stone & Burnet (I946) suggested that the failure of calf dermis to show specific haemagglutinin might be due in part to destruction of material in superficial necrotic tissue by oxidation and in part to combination of material with 'precocious antibody'. In support of this view they showed that calf lymph inhibited vaccinia haemagglutinin at a dilution of 1/25. It seems unlikely that the haemagglutinin inhibitor in calf dermis is an immunoglobulin, however, since it is present in the dermis only 5 days after infection. Moreover, unlike most immunoglobulins it combines with DEAE-Sephadex at low salt concentration and its combination with haemagglutinin is reversed by ultrasonic treatment. From this last observation it is unlikely also that the inhibitor is an enzyme destroying haemagglutinin activity; such a suggestion was made by Cassel & Fater 0957) for a non-specific inhibitor of vaccinia haemagglutinin, which they detected in cell-free plasma from Ehrlich ascites tumours.
